Latest News & Updates
A round-up of new drugs that are being investigated as treatments for genitourinary cancers.
The 12-month countdown to the adoption of ICD-10 has begun. ICD-10 represents the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (usually referred to as “ICD”), now overseen by the World Health Organization (WHO).
Even as more hospitals seek to acquire medical groups and physician practices, this consolidation leads to higher expenditures through greater use of hospital-based ambulatory services, according to a recent study from the University of California, Berkeley School of Public Health.
How can we slow down the growth of cancer costs and preserve—or better yet—enhance clinical outcomes?
Virtually everyone in the clinical laboratory business is now acquainted with Z-code identifiers. Each unique laboratory test should have a unique tracking code, even if more than one Z-code identifier is reported with a corresponding American Medical Association’s Current Procedural Terminology (CPT) billing code.
Latest Peer Exchange Discussions
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer. View Now
H. Jack West, MD, discusses next-generation ALK inhibitors in development and approved for patients with non-small cell lung cancer. View Now
Panelists discuss the role of checkpoint inhibition in renal cell carcinoma, which appears to be less clear than in other tumor types due to a multitude of existing effective therapies. View Now
Most Popular Right Now
Online CME Activities